Hyong Un, MD

Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.

Federal parity led to an increase in spending on substance use disorder treatment.

A large proportion of opioid analgesic treated chronic pain patients exhibited behaviors indicative of potentially problematic opioid use, which significantly affected healthcare costs.